Related Experiment Video
Updated: Oct 7, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants
Gerardo Mata-Torres1, Adolfo Andrade-Cetto1, Fernanda Espinoza-Hernández1
1Laboratorio de Etnofarmacología, Departamento de Biología Celular, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Medicinal plants offer natural compounds that can improve liver glucose metabolism by inhibiting protein tyrosine phosphatase 1B and regulating key enzymes. Coreopsis tinctoria, Lithocarpus polystachyus, and Panax ginseng show promise for developing phytomedicines to combat hyperglycemia.
Area of Science:
- Biochemistry
- Pharmacology
- Metabolic Disorders
Background:
- The liver is central to glucose homeostasis, regulating blood glucose through production, storage, and disposal.
- Insulin resistance in the liver leads to hyperglycemia, common in obesity and diabetes, due to dysregulated glucose production and storage.
- Two therapeutic strategies target hepatic insulin resistance: enhancing insulin signaling and directly modulating key metabolic enzymes.
Purpose of the Study:
- To review recent advancements in medicinal plants for improving hepatic glucose metabolism.
- To explore plant-derived compounds targeting protein tyrosine phosphatase 1B (PTP-1B) and gluconeogenic enzymes.
- To identify promising plant candidates for phytomedicine development against hyperglycemia.
Main Methods:
- Literature review focusing on research from the past 7 years.
- Analysis of plant compounds, particularly phenolics and terpenoids, for their effects on PTP-1B activity.
- Investigation of plant-derived molecule impacts on key enzymes in gluconeogenesis and glycogen metabolism.
Main Results:
- Medicinal plants contain compounds, like phenolics and terpenoids, that inhibit PTP-1B, a key disruptor of insulin signaling.
- Certain plant molecules effectively decrease the expression or activity of gluconeogenic enzymes such as phosphoenolpyruvate carboxykinase and glucose 6-phosphatase.
- Coreopsis tinctoria, Lithocarpus polystachyus, and Panax ginseng were identified as promising candidates for modulating hepatic glucose output.
Conclusions:
- Medicinal plants provide a rich source of bioactive compounds for managing hepatic glucose metabolism.
- Targeting PTP-1B and key gluconeogenic enzymes with plant-derived molecules offers a viable therapeutic strategy for hyperglycemia.
- Coreopsis tinctoria, Lithocarpus polystachyus, and Panax ginseng demonstrate potential for developing novel phytomedicines to restore glucose homeostasis.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon